Final results of the STEM trial: SFX-01 in the Treatment and Evaluation of Metastatic breast cancer, presented at ESMO 2019 steve | 27 September 2019
Novel biomarkers for sulforaphane treated patients in ER+/HER- metastatic breast cancer, presented at ABPP 2019 steve | 28 March 2019
SFX-01 targets STAT3 signalling to inhibit stem-like cells in breast cancer patient-derived xenograft tumours, presented at the UK Interdisciplinary Breast Cancer Symposium 2018 steve | 15 January 2018
STEM Trial: SFX-01 in the Treatment and Evaluation of Metastatic breast cancer, presented at the San Antonio Breast Cancer Symposium 2018 steve | 4 December 2018
